Holen Sie sich die Stockscreener-App
1.11
0.89%
-0.01
Handel nachbörslich:
1.12
0.01
+0.90%
Schlusskurs vom Vortag:
$1.12
Offen:
$1.11
24-Stunden-Volumen:
2.65M
Relative Volume:
0.68
Marktkapitalisierung:
$246.29M
Einnahmen:
$95,000
Nettoeinkommen (Verlust:
$-327.27M
KGV:
-0.5236
EPS:
-2.12
Netto-Cashflow:
$-239.25M
1W Leistung:
-5.93%
1M Leistung:
+0.91%
6M Leistung:
-41.58%
1J Leistung:
-56.98%
1-Tages-Spanne:
$1.06
$1.1371
1-Wochen-Bereich:
$1.06
$1.2065
52-Wochen-Spanne:
$0.8621
$3.78
Allogene Therapeutics Inc Stock (ALLO) Company Profile
Firmenname
Allogene Therapeutics Inc
Sektor
Branche
Telefon
(650) 457-2700
Adresse
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALLO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLO
Allogene Therapeutics Inc
|
1.11 | 248.51M | 95,000 | -327.27M | -239.25M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-08-08 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-05 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-01-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-08 | Eingeleitet | Citigroup | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-01-06 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-12-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-08-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-15 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-03 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-02-28 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-20 | Eingeleitet | Cowen | Outperform |
| 2021-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2021-10-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-06-21 | Fortgesetzt | Jefferies | Buy |
| 2021-05-20 | Hochstufung | Truist | Hold → Buy |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-26 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-10 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-11-24 | Eingeleitet | BofA Securities | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-06-01 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-05-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-19 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-15 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-14 | Herabstufung | SunTrust | Buy → Hold |
| 2020-04-13 | Eingeleitet | SunTrust | Buy |
| 2020-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-05 | Eingeleitet | Stifel | Hold |
| 2020-02-24 | Eingeleitet | Berenberg | Hold |
| 2019-12-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-11-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-06-05 | Eingeleitet | ROTH Capital | Neutral |
| 2019-05-31 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-23 | Eingeleitet | Stifel | Hold |
| 2019-03-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Allogene Therapeutics Inc Aktie (ALLO) Neueste Nachrichten
Is Allogene Therapeutics Inc. stock influenced by commodity pricesLong Setup & Weekly Momentum Stock Picks - khodrobank.com
Order flow analysis tools used on Allogene Therapeutics Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Will Allogene Therapeutics Inc. outperform its industry peersJuly 2025 Big Picture & Daily Volume Surge Signals - khodrobank.com
Intraday pattern recognizer results for Allogene Therapeutics Inc.2025 Technical Patterns & Real-Time Volume Analysis Alerts - Newser
Will Allogene Therapeutics Inc. benefit from current market trendsDividend Hike & Weekly Momentum Stock Picks - khodrobank.com
How institutional ownership impacts Allogene Therapeutics Inc. stock2025 Market WrapUp & Safe Entry Point Identification - Newser
Will Allogene Therapeutics Inc. outperform the marketJuly 2025 Outlook & Safe Capital Preservation Plans - Newser
Can Allogene Therapeutics Inc. be the next market leaderWeekly Profit Recap & Capital Efficient Trading Techniques - khodrobank.com
Why Allogene Therapeutics Inc. is moving todayJobs Report & High Accuracy Trade Alerts - Newser
Volume spikes in Allogene Therapeutics Inc. stock – what they meanPortfolio Return Report & Real-Time Buy Zone Alerts - Newser
Real time pattern detection on Allogene Therapeutics Inc. stockMarket Growth Report & Reliable Price Breakout Alerts - Newser
What MACD signals say about Allogene Therapeutics Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Should you hold or exit Allogene Therapeutics Inc. nowTrade Ideas & Low Risk Investment Opportunities - Newser
Key metrics from Allogene Therapeutics Inc.’s quarterly data2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Should you wait for a breakout in Allogene Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What earnings revisions data tells us about Allogene Therapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - Newser
Is it too late to sell Allogene Therapeutics Inc.Quarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Has Allogene Therapeutics Inc. found a price floorJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Exit strategy if you’re trapped in Allogene Therapeutics Inc.Market Trend Review & High Conviction Buy Zone Picks - Newser
Is Allogene Therapeutics Inc. reversing from oversold territoryJuly 2025 Short Interest & Smart Money Movement Alerts - Newser
What momentum shifts mean for Allogene Therapeutics Inc.Weekly Trade Analysis & Low Drawdown Momentum Ideas - Newser
Allogene Therapeutics Inc. stock trend outlook and recovery pathWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Allogene Therapeutics Inc. stock outlook for YEAREarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Evaluating Allogene Therapeutics Inc. with trendline analysisPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Allogene Therapeutics Inc. building a consolidation baseWeekly Trading Summary & Daily Profit Focused Stock Screening - Newser
Allogene Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline - Investing.com
Comparing Allogene Therapeutics Inc. in custom built stock radarsJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Can Allogene Therapeutics Inc. sustain earnings growthJuly 2025 Decliners & Weekly High Return Forecasts - khodrobank.com
Visual analytics tools that track Allogene Therapeutics Inc. performanceWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Full technical analysis of Allogene Therapeutics Inc. stock2025 Market Outlook & Risk Managed Investment Signals - Newser
Backtesting results for Allogene Therapeutics Inc. trading strategiesJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
How to recover losses in Allogene Therapeutics Inc. stockTrade Ideas & Risk Managed Investment Entry Signals - Newser
Using Ichimoku Cloud for Allogene Therapeutics Inc. technicalsInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How to manage a losing position in Allogene Therapeutics Inc.CPI Data & Reliable Breakout Forecasts - Newser
Applying Wyckoff theory to Allogene Therapeutics Inc. stockJuly 2025 Outlook & Technical Pattern Alert System - Newser
Allogene Therapeutics Earnings Call: Progress Amid Challenges - TipRanks
Momentum divergence signals in Allogene Therapeutics Inc. chartEarnings Beat & Technical Pattern Alert System - Newser
Visualizing Allogene Therapeutics Inc. stock with heatmapsJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Volatility clustering patterns for Allogene Therapeutics Inc.July 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):